Clinical trials
Phase 3 Eye Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 7 |
| Terminated | 5 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kodiak Sciences Inc | 6 |
| GenSight Biologics | 4 |
| Novartis Pharmaceuticals | 4 |
| Vanda Pharmaceuticals | 4 |
| LENZ Therapeutics, Inc | 3 |
| Adverum Biotechnologies, Inc. | 2 |
| University of California, San Francisco | 2 |
| 4D Molecular Therapeutics | 1 |
| AbbVie | 1 |
| Alcon Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eye Diseases | 45 |
| Retinal Diseases | 17 |
| Retinal Degeneration | 11 |
| Vision Disorders | 11 |
| Blindness | 9 |
| Macular Degeneration | 8 |
| Nervous System Diseases | 7 |
| Wet Macular Degeneration | 6 |
| Diabetic Retinopathy | 5 |
| Eye Diseases, Hereditary | 5 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.